Vertex Pharmaceuticals (VRTX) News Today $443.01 -4.08 (-0.91%) Closing price 04:00 PM EasternExtended Trading$441.46 -1.55 (-0.35%) As of 05:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock VRTX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period When Stocks Slide, These Are the Sectors That Do BestMay 30 at 3:15 PM | msn.comVertex Pharmaceuticals Incorporated (VRTX) Bernstein 41st Annual Strategic Decisions Conference (Transcript)May 30 at 11:09 AM | seekingalpha.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Purchased by Boston Common Asset Management LLCBoston Common Asset Management LLC raised its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 1.3% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 50,963 shares of the pharmaceutical compMay 30 at 7:36 AM | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Stock Position Raised by MassMutual Private Wealth & Trust FSBMassMutual Private Wealth & Trust FSB lifted its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 172.6% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 17,016 shares of the pharmaceMay 30 at 6:29 AM | marketbeat.comDSG Capital Advisors LLC Buys New Shares in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)DSG Capital Advisors LLC purchased a new stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 3,625 shares of the pharmaceutical companMay 29 at 7:48 AM | marketbeat.com111 Capital Makes New Investment in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)111 Capital purchased a new stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 3,304 shares of the pMay 29 at 7:39 AM | marketbeat.comLansforsakringar Fondforvaltning AB publ Takes $58.27 Million Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Lansforsakringar Fondforvaltning AB publ bought a new position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The fund bought 144,708 shares of the pharmaceutical company's stock, valued at aMay 29 at 7:00 AM | marketbeat.comPKO Investment Management Joint Stock Co Invests $3.06 Million in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)PKO Investment Management Joint Stock Co acquired a new position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 7,600 shares of the pharmaceutical company'May 29 at 6:52 AM | marketbeat.comWealthedge Investment Advisors LLC Makes New Investment in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Wealthedge Investment Advisors LLC acquired a new position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 2,221 sMay 29 at 6:34 AM | marketbeat.comLighthouse Financial LLC Purchases Shares of 3,705 Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Lighthouse Financial LLC purchased a new stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 3,705 shares of theMay 29 at 6:26 AM | marketbeat.comIronOak Wealth LLC. Invests $623,000 in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)IronOak Wealth LLC. acquired a new position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 1,546 sharMay 29 at 5:54 AM | marketbeat.comBridgePort Financial Solutions LLC Makes New Investment in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)BridgePort Financial Solutions LLC bought a new position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 794May 29 at 5:44 AM | marketbeat.comTFR Capital LLC. Makes New $1.84 Million Investment in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)TFR Capital LLC. purchased a new stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 4,561 shares of the pharmaceuticalMay 28 at 7:26 AM | marketbeat.comEmployees Retirement System of Texas Grows Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Employees Retirement System of Texas raised its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 3.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 121,600 shares of the pharmaceuticalMay 28 at 7:21 AM | marketbeat.comJefferies Financial Group Inc. Sells 18,659 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Jefferies Financial Group Inc. trimmed its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 57.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 13,984 shares of the pharmaMay 28 at 7:02 AM | marketbeat.comSiemens Fonds Invest GmbH Sells 1,648 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Siemens Fonds Invest GmbH cut its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 13.1% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 10,919 shares of the pharmaceutical compMay 28 at 6:47 AM | marketbeat.comUniversal Beteiligungs und Servicegesellschaft mbH Takes Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor pMay 28 at 6:13 AM | marketbeat.comB. Riley Wealth Advisors Inc. Has $2.87 Million Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)B. Riley Wealth Advisors Inc. reduced its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 20.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 7,115 shares of the pharmaceutical company's stock afterMay 28 at 6:00 AM | marketbeat.com892 Shares in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Acquired by Armis Advisers LLCArmis Advisers LLC bought a new position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor bought 892 shares of the pharmaceutical company's stock, valued at approximMay 28 at 6:00 AM | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Acquired by Great Valley Advisor Group Inc.Great Valley Advisor Group Inc. raised its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 12.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 20,593 shares of the pharMay 28 at 5:40 AM | marketbeat.comIntegrated Advisors Network LLC Has $1.24 Million Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Integrated Advisors Network LLC decreased its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 17.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,080 shares of the pharmaceutiMay 28 at 5:36 AM | marketbeat.comMackenzie Financial Corp Lowers Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Mackenzie Financial Corp lessened its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 33.6% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 45,632 shares of the pharmaceutical company's stock after selMay 28 at 5:15 AM | marketbeat.comToronto Dominion Bank Decreases Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Toronto Dominion Bank decreased its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 19.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 107,834 shares of tMay 28 at 5:07 AM | marketbeat.comPolar Asset Management Partners Inc. Invests $22.95 Million in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Polar Asset Management Partners Inc. bought a new position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 57,000 shares of the pharmaceutical company's stoMay 27 at 7:07 AM | marketbeat.comPutney Financial Group LLC Purchases New Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Putney Financial Group LLC purchased a new stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor purchased 955 shares of the pharmaceutical company's stock, valued at aMay 27 at 6:03 AM | marketbeat.comVise Technologies Inc. Grows Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Vise Technologies Inc. raised its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 141.5% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,809 shares of the pMay 27 at 4:57 AM | marketbeat.comSunbelt Securities Inc. Sells 646 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Sunbelt Securities Inc. decreased its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 38.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,035 shares of the pharmaceutical compaMay 27 at 4:56 AM | marketbeat.comMontchanin Asset Management LLC Sells 1,620 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Montchanin Asset Management LLC decreased its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 14.2% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 9,802 shares ofMay 26, 2025 | marketbeat.comVertex Pharmaceuticals Q1 Earnings TranscriptMay 26, 2025 | marketbeat.comGF Fund Management CO. LTD. Takes $23.83 Million Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)GF Fund Management CO. LTD. acquired a new stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 59,178 shares of theMay 26, 2025 | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Sold by Public Employees Retirement System of OhioPublic Employees Retirement System of Ohio decreased its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 5.0% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 115,847 shares of the pharmaceutical company's stockMay 26, 2025 | marketbeat.comGTS Securities LLC Trims Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)GTS Securities LLC lessened its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 54.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 3,329 shares of the pharmaceutical company's stock after selMay 26, 2025 | marketbeat.com3 Top Growth Stocks to Buy in the Second Half of 2025May 26, 2025 | fool.comTwo Sigma Investments LP Trims Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Two Sigma Investments LP lowered its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 79.3% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 33,160 shares of the pharmaceutical company's stock after selling 127,375 sharMay 26, 2025 | marketbeat.comInvestment Management Corp VA ADV Takes Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Investment Management Corp VA ADV purchased a new stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 838 shares of the pharmaceutical company's stMay 25, 2025 | marketbeat.comBreed s Hill Capital LLC Takes $498,000 Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Breed s Hill Capital LLC purchased a new stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 1,236 shares of the pharmaceuticalMay 25, 2025 | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Bought by Waverly Advisors LLCWaverly Advisors LLC increased its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 632.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,948 shares of the pharmaceuMay 25, 2025 | marketbeat.com2 Monster Growth Stocks to Buy and Hold for 10 YearsMay 24, 2025 | fool.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Sold by JT Stratford LLCJT Stratford LLC decreased its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 55.5% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,956 shares of the pharmaceutical company's stMay 24, 2025 | marketbeat.comHarmony Asset Management LLC Has $2.53 Million Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Harmony Asset Management LLC cut its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 9.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 6,275 shares of the pharmaceutical company's stockMay 24, 2025 | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Sold by Voloridge Investment Management LLCVoloridge Investment Management LLC reduced its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 49.1% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 69,712 shares of the pharmaceuMay 24, 2025 | marketbeat.comCastleark Management LLC Sells 36,240 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Castleark Management LLC trimmed its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 43.8% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 46,485 shares of the pharmaceutical company's stockMay 23, 2025 | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Bought by BRITISH COLUMBIA INVESTMENT MANAGEMENT CorpBRITISH COLUMBIA INVESTMENT MANAGEMENT Corp boosted its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 195.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 127,324 sharesMay 23, 2025 | marketbeat.comUSS Investment Management Ltd Sells 2,996 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)USS Investment Management Ltd reduced its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 6.3% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 44,403 shares of the pharmaceutical company's stock afterMay 23, 2025 | marketbeat.comZurich Insurance Group Ltd FI Reduces Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Zurich Insurance Group Ltd FI trimmed its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 3.3% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 51,5May 23, 2025 | marketbeat.comWestwood Holdings Group Inc. Makes New $1.28 Million Investment in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Westwood Holdings Group Inc. purchased a new position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 3,165 shares ofMay 23, 2025 | marketbeat.comPrincipal Street Partners LLC Cuts Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Principal Street Partners LLC trimmed its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 25.0% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,258 shares of the pharmaceutical coMay 22, 2025 | marketbeat.comLantern Wealth Advisors LLC Buys 650 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Lantern Wealth Advisors LLC boosted its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 72.2% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,550 shares ofMay 22, 2025 | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Trims Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lessened its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 4.6% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,329,219 shares oMay 22, 2025 | marketbeat.comWoodline Partners LP Acquires 16,653 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Woodline Partners LP raised its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 12.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 149,418 shares of the pharmaceuticalMay 22, 2025 | marketbeat.com Get Vertex Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for VRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address VRTX Media Mentions By Week VRTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VRTX News Sentiment▼1.560.88▲Average Medical News Sentiment VRTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VRTX Articles This Week▼4228▲VRTX Articles Average Week Get Vertex Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for VRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Amgen News Gilead Sciences News Regeneron Pharmaceuticals News Alnylam Pharmaceuticals News Biogen News United Therapeutics News Incyte News Neurocrine Biosciences News Exelixis News BioMarin Pharmaceutical News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VRTX) was last updated on 5/30/2025 by MarketBeat.com Staff From Our PartnersAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredThe Social Security Changes No One’s Talking AboutWhile most Americans worry about their next Social Security check... something far bigger is happening behind ...Altimetry | SponsoredUrgent: Make this trade before you hit your pillow tonight… Most people waste 8 hours every night… And 227,916 hours in their lifetime… Dreaming about the life they...Timothy Sykes | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredHISTORIC Gold Move Sends Flashing Red Signal To 401K SaversHistorically, when panic hits Wall Street, investors rush to raise cash to cover their leveraged positions be ...Colonial Metals | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vertex Pharmaceuticals Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Vertex Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VRTX Stock Free VRTX Stock Alerts